161 related articles for article (PubMed ID: 18832042)
1. Improvement of microcirculation after percutaneous transluminal angioplasty in the lower limb with prostaglandin E1.
Heider P; Wildgruber M; Wolf O; Schuster T; Lutzenberger W; Berger H; Eckstein HH
Prostaglandins Other Lipid Mediat; 2009 Jan; 88(1-2):23-30. PubMed ID: 18832042
[TBL] [Abstract][Full Text] [Related]
2. Transcutaneous oximetry compared to ankle-brachial-index measurement in the evaluation of percutaneous transluminal angioplasty.
Wildgruber M; Wolf O; Weiss W; Berger H; Lutzenberger W; Eckstein HH; Heider P
Eur J Radiol; 2007 Nov; 64(2):302-8. PubMed ID: 17386992
[TBL] [Abstract][Full Text] [Related]
3. Intra-arterial and intravenous administration of prostaglandin E1 cause different changes to skin microcirculation in patients with peripheral arterial occlusive disease.
Thum J; Caspary L; Creutzig A; Alexander K
Vasa; 1998 May; 27(2):100-5. PubMed ID: 9612114
[TBL] [Abstract][Full Text] [Related]
4. Midterm results of prostaglandin E1 treatment in patients with lumbar spinal canal stenosis accompanied by intermittent claudication.
Nakanishi K; Tanaka M; Misawa H; Takigawa T; Ozaki T
Spine (Phila Pa 1976); 2008 Jun; 33(13):1465-9. PubMed ID: 18520942
[TBL] [Abstract][Full Text] [Related]
5. Does percutaneous transluminal angioplasty improve quality of life?
Keeling AN; Naughton PA; O'Connell A; Lee MJ
J Vasc Interv Radiol; 2008 Feb; 19(2 Pt 1):169-76. PubMed ID: 18341944
[TBL] [Abstract][Full Text] [Related]
6. Intravenous prostaglandin E1 reduces monocyte chemoattractant protein-1 levels in peripheral arterial obstructive disease.
Matsui K; Ikeda U; Murakami Y; Yoshioka T; Shimada K
Am Heart J; 2003 Feb; 145(2):330-3. PubMed ID: 12595852
[TBL] [Abstract][Full Text] [Related]
7. Progress in the prostaglandin E1-therapy of the intermittent claudication by means of bolus injections of LIPO-prostaglandin E1 (LIPO-PGE1).
Scheffler P; Gross J; Markwirth T; Maier J; Schieffer H
Eur J Clin Pharmacol; 1996; 51(3-4):235-9. PubMed ID: 9010691
[TBL] [Abstract][Full Text] [Related]
8. Microcirculation and tolerability following i.v. infusion of PGE1 and iloprost: a randomized cross-over study in patients with critical limb ischemia.
Schellong S; Altmann E; von Bilderling P; Rudofsky G; Waldhausen P; Rogatti W
Prostaglandins Leukot Essent Fatty Acids; 2004 Jun; 70(6):503-9. PubMed ID: 15120713
[TBL] [Abstract][Full Text] [Related]
9. Prostaglandin E1 -containing nanoparticles improve walking activity in an experimental rat model of intermittent claudication.
Ishihara T; Yamashita Y; Takasaki N; Yamamoto S; Hayashi E; Tahara K; Takenaga M; Yamakawa N; Ishihara T; Kasahara T; Mizushima T
J Pharm Pharmacol; 2013 Aug; 65(8):1187-94. PubMed ID: 23837586
[TBL] [Abstract][Full Text] [Related]
10. Beneficial effects of intravenous administration of lipo-prostaglandin E1 on the ischemic gastric tube in pigs.
Tobari S; Ikeda Y; Takami H
J Surg Res; 2005 Nov; 129(1):79-84. PubMed ID: 16087193
[TBL] [Abstract][Full Text] [Related]
11. Neutrophil function in peripheral arterial occlusive disease: the effects of prostaglandin E1.
Weiss T; Eckstein H; Weiss C; Diehm C
Vasc Med; 1998; 3(3):171-5. PubMed ID: 9892509
[TBL] [Abstract][Full Text] [Related]
12. Intermittent intraarterial infusion therapy with PGE1 in patients with severe claudication--results of a randomized prospective double blind study.
Caspary L; Creutzig A; Radeke U; Specht S; Alexander K
Biomed Biochim Acta; 1988; 47(10-11):S307-10. PubMed ID: 3073766
[TBL] [Abstract][Full Text] [Related]
13. Impact of a 4-week treatment with prostaglandin E1 on health-related quality of life of patients with intermittent claudication.
Mangiafico RA; Messina R; Attinà T; Dell'Arte S; Giuliano L; Malatino LS
Angiology; 2000 Jun; 51(6):441-9. PubMed ID: 10870853
[TBL] [Abstract][Full Text] [Related]
14. [Intermittent intra-arterial infusion treatment of severe intermittent claudication. Results of a prospective double-blind study: prostaglandin El versus energy-rich phosphates].
Creutzig A; Caspary L; Radeke U; Specht S; Ranke C; Alexander K
Med Klin (Munich); 1988 Jun; 83(13-14):434-8. PubMed ID: 3062344
[No Abstract] [Full Text] [Related]
15. [Severe intermittent claudication: PGE1 treatment. A 40-week registry, efficacy and costs].
Luzzi R; Belcaro G; Ippolito E; Dugall M; Cesarone MR; Scoccianti M; Errichi BM; Pellegrini L; Ciammaichella G; Ledda A; Ricci A; Cornelli U; Feragalli B; Hosoi M; Corsi M; Simeone E; Agus GB
Minerva Cardioangiol; 2012 Aug; 60(4):405-13. PubMed ID: 22858918
[TBL] [Abstract][Full Text] [Related]
16. [Analysis of costs and results of prostaglandin (PGE1 alpha-cyclodestrin) therapy of peripheral arterial diseases].
Bucci M; Iacobitti P; Laurora G; Cesarone MR
Minerva Cardioangiol; 1998 Oct; 46(10 Suppl 1):9-15. PubMed ID: 10658439
[TBL] [Abstract][Full Text] [Related]
17. Iontophoretic application of prostaglandin E1 for improvement in peripheral microcirculation.
Saeki S; Yamamura K; Matsushita M; Nishikimi N; Sakurai T; Nimura Y
Int J Clin Pharmacol Ther; 1998 Oct; 36(10):525-9. PubMed ID: 9799055
[TBL] [Abstract][Full Text] [Related]
18. Treatment of severe intermittent claudication with PGE1--a short-term vs a long-term infusion plan--a 20 week, European randomized trial--analysis of efficacy and costs.
Belcaro G; Laurora G; Nicolaides AN; Agus G; Cesarone MR; DeSanctis MT; Incandela L; Ricci A; Cazaubon M; Ippolito E; Barsotti A; Vasdekis S; Ledda A; Iacobitti P; Christopoulos D; Errichi BM; Helmis H; Cornelli U; Ramaswami G; Bucci M; Ferrari PG; Corsi M; Pomante P; Mezzanotte L; Geroulakos G
Angiology; 1998 Nov; 49(11):885-94; discussion 895. PubMed ID: 9822044
[TBL] [Abstract][Full Text] [Related]
19. Efficacy of a new prostaglandin E1 regimen in outpatients with severe intermittent claudication: results of a multicenter placebo-controlled double-blind trial.
Diehm C; Balzer K; Bisler H; Bulling B; Camci M; Creutzig A; Gruss JD; Horsch S; Odemar F; Piehler U; Rogatti W; Scheffler P; Spengel F; Treese N; Turowski A; Waldhausen P; Weber B; Weiss T
J Vasc Surg; 1997 Mar; 25(3):537-44. PubMed ID: 9081136
[TBL] [Abstract][Full Text] [Related]
20. Effects of intravenous prostaglandin E1 on arterial compliance: a randomized controlled trial.
Mlekusch W; Schillinger M; Sabeti S; Al-Awami M; Gschwandtner M; Minar E
Vasa; 2004 Aug; 33(3):131-6. PubMed ID: 15461064
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
